Current Diabetes Reports

, Volume 5, Issue 6, pp 455–463

Early nephropathy in type 1 diabetes: A new perspective on who will and who will not progress

  • Bruce A. Perkins
  • Andrzej S. Krolewski

DOI: 10.1007/s11892-005-0055-7

Cite this article as:
Perkins, B.A. & Krolewski, A.S. Curr Diab Rep (2005) 5: 455. doi:10.1007/s11892-005-0055-7


Impaired renal function and end-stage renal disease (ESRD) affect up to a third of patients with type 1 diabetes. Thus, strategies for early detection and for preventative interventions are of critical importance. A model of diabetic nephropathy was developed in the 1980s that placed paramount importance on the finding of microalbuminuria as an early marker of a committed process of progressive kidney disease in diabetes. However, recent studies have provided evidence that microalbuminuria is a marker of dynamic, rather than fixed, kidney injury. Preliminary studies into early renal function decline, a process measured in early nephropathy using a simple assay for cystatin C to calculate the slope of glomerular filtration rate change over time, suggest that it is a more proximal marker than microalbuminuria of a person’s trajectory toward impaired renal function and ESRD. Therefore, early renal function decline, rather than microalbuminuria, may be considered as the early marker of the committed process underlying progressive diabetic nephropathy.

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Bruce A. Perkins
  • Andrzej S. Krolewski
    • 1
  1. 1.Section on Genetics and EpidemiologyJoslin Diabetes CenterBostonUSA

Personalised recommendations